Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9694369
Reference Type
Journal Article
Subtype
Review
Title
Tiratricol-induced periodic paralysis: a review of nutraceuticals affecting thyroid function
Author(s)
Cohen-Lehman, J; Charitou, MM; Klein, I
Year
2011
Is Peer Reviewed?
Yes
Journal
Endocrine Practice
ISSN:
1530-891X
EISSN:
1934-2403
Publisher
American Association of Clinical Endocrinologists
Volume
17
Issue
4
Page Numbers
610-615
Language
English
PMID
21803722
DOI
10.4158/EP10137.RA
Web of Science Id
WOS:000294276000011
URL
https://www.proquest.com/scholarly-journals/tiratricol-induced-periodic-paralysis-review/docview/1827920991/se-2?accountid=171501
Exit
Abstract
OBJECTIVE:
To review the potential adverse effects of thyroid hormone-based nutraceuticals and describe a case of thyrotoxic periodic paralysis (TPP) after abuse of a dietary supplement containing 3,5,3'-triiodothyroacetic acid (tiratricol).
METHODS:
We review the literature on potential dangers and therapeutic misadventures of thyroid hormone-based nutraceuticals and present the clinical, laboratory, and radiologic data of a bodybuilder in whom hypokalemic TPP developed after use of "Triax Metabolic Accelerator".
RESULTS:
A 23-year-old white man developed lower extremity paralysis, diaphoresis, and palpitations in the setting of low serum potassium levels. Laboratory results showed suppressed thyroid-stimulating hormone, low levels of free and total thyroxine, low total triiodothyronine level, and very low 24-hour radioiodine uptake. The patient ultimately admitted to taking a supplement containing tiratricol for approximately 2 months, and hypokalemic TPP was diagnosed. He was treated with potassium supplementation and a β-adrenergic blocking agent, which completely resolved his symptoms. Results of thyroid function tests normalized or approached normal 1 week after hospitalization, and future use of dietary supplements was strongly discouraged. Despite 2 warnings by the US Food and Drug Administration, products containing tiratricol are still available for sale on the Internet.
CONCLUSION:
This report illustrates both an unusual adverse effect of a nutraceutical containing tiratricol and the importance of educating our patients about the risks versus benefits of using these widely available but loosely regulated products.
Keywords
Biotechnology and Bioengineering Abstracts; Abuse; Dietary supplements; Data processing; Thyroid-stimulating hormone; Side effects; Reviews; nutraceuticals; Thyroxine; Triiodothyronine; Paralysis; Thyroid hormones; Potassium; W 30935:Food Biotechnology
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity